Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of EndodonticsReferences
- Glossary of Endodontic Terms.Tenth Edition. 2020
- Identify and define all diagnostic terms for pulpal health and disease states.J Endod. 2009; 35: 1645-1657
- Dental pulp testing: a review.Int J Dent. 2009; 2009: 365785
- Mechanisms and management of pain due to inflammation.Northwest Dent. 1991; 70: 47-49
- Pain pathways and mechanisms of the pulpdentin complex.in: Hargreaves K.M. Goodis H.E. Tay F.R. Seltzer's and Bender's dental pulp. 2nd ed. Quintessence Publ, Hannover Park, IL2012
- The incidence of mechanical allodynia in patients with irreversible pulpitis.J Endod. 2007; 33: 552-556
- Treatment of deep caries, vital pulp exposure, and pulpless teeth.in: Dean J.A. Avery D.R. McDonald R.E. McDonald and Avery's dentistry of the child and adolescent. 9th ed. Mosby/Elsevier, St. Louis, MO2011
- Diagnosis of diseases of the pulp.Oral Surg Oral Med Oral Pathol. 1970; 29: 102-116
- Clinical signs and symptoms in pulp disease.Int Endod J. 1980; 13: 27-35
- Call for a review of diagnostic nomenclature and terminology used in endodontics.Int Endod J. 2020; (in press)
- Vital pulp therapy: histopathology and histobacteriology- based guidelines to treat teeth with deep caries and pulp exposure.J Dent. 2019; 86: 41-52
- Minimally invasive endodontics: a new diagnostic system for assessing pulpitis and subsequent treatment needs.Int Endod J. 2017; 50: 825-829
- Biological markers for pulpal inflammation: a systematic review.PLoS One. 2016; 11: e0167289
- Pulp inflammation diagnosis from clinical to inflammatory mediators: a systematic review.J Endod. 2017; 43: 1033-1051
- A first study on the usefulness of matrix metalloproteinase 9 from dentinal fluid to indicate pulp inflammation.J Endod. 2011; 37: 17-20
- A prospective clinical pilot study on the level of matrix metalloproteinase-9 in dental pulpal blood as a marker for the state of inflammation in the pulp tissue.J Endod. 2016; 42: 190-197
- Vital pulp therapy.in: Berman L. Hargreaves K.M. Pathways of the pulp. 12th ed. Elsevier, St. Louis, MO2021
- Vital pulp therapy of mature permanent teeth with irreversible pulpitis from the perspective of pulp biology.Aust Endod J. 2020; 46: 154-165
- Treatment outcomes of 4 vital pulp therapies in mature molars.J Endod. 2018; 44: 529-535
- A clinical study of direct pulp capping applied to carious-exposed pulps.J Endod. 1996; 22: 551
- Pulp and dentine responses to selective caries excavation: a histological and histobacteriological human study.J Dent. 2020; 100: 103430
- Bacteriologic status of non-cavitated proximal enamel caries lesions. a histologic and histobacteriologic study.J Dent. 2020; 100: 103422
- Tensile bond strength and SEM evaluation of caries-affected dentin using dentin adhesives.J Dent Res. 1995; 74: 1679-1688
- Resin adhesion to carious dentin.Am J Dent. 2003; 16: 47-52
- Evaluation of a new caries detecting dye for primary and permanent carious dentin.J Dent. 2007; 35: 137-143
- Caries-removal effectiveness and minimal-invasiveness potential of caries-excavation techniques: a micro-CT investigation.J Dent. 2011; 39: 154-162
- Evaluation of the efficacy of visual, tactile method, caries 26 detector dye, and laser fluorescence in removal of dental caries and confirmation by culture and polymerase chain reaction: an in vivo study.J Pharm Bioallied Sci. 2019; 11: S146-S150
- Management of the inflamed pulp associated with deep carious lesion.J Endod. 1981; 7: 169
- Two layers of carious dentin: diagnosis and treatment.Oper Dent. 1979; 4: 63-70
- An in vivo evaluation of hemorrhage control using sodium hypochlorite and direct capping with a one- or two-component adhesive system in exposed nonhuman primate pulps.Quintessence Int. 2002; 33: 261-272
- Prognostic factors for clinical outcomes according to time after direct pulp capping.J Endod. 2013; 39: 327-331
- A randomized controlled study of the use of proroot mineral trioxide aggregate and endocem as direct pulp capping materials: 3-month versus 1-year outcomes.J Endod. 2015; 41: 1201-1206
- A randomized controlled trial of various MTA materials for partial pulpotomy in permanent teeth.J Dent. 2017; 60: 8-13
- Capping carious exposures in adults: a randomized controlled trial investigating mineral trioxide aggregate versus calcium hydroxide.Int Endod J. 2017; 50: 924-932
- Treatment outcomes of mineral trioxide aggregate pulpotomy in vital permanent teeth with carious pulp exposure: the retrospective study.J Endod. 2017; 43: 225-230
- Treatment outcome following direct pulp capping using bioceramic materials in mature permanent teeth with carious exposure: a pilot retrospective study.J Endod. 2017; 43: 1635-1639
- Outcomes of direct pulp capping by using either proroot mineral trioxide aggregate or Biodentine™ in permanent teeth with carious pulp exposure in 6- to 18-year-old patients: a randomized controlled trial.J Endod. 2018; 44: 341-348
- Mineral trioxide aggregate pulpotomy for permanent molars with clinical signs indicative of irreversible pulpitis: a preliminary study.Int Endod J. 2017; 50: 126-134
- Success of direct pulp capping using mineral trioxide aggregate and calcium hydroxide in mature permanent molars with pulps exposed during carious tissue removal: 1-year follow-up.J Endod. 2019; 45: 840-847
- Outcome of full pulpotomy using Biodentine™ in adult patients with symptoms indicative of irreversible pulpitis.Int Endod J. 2018; 51: 819-828
- Full pulpotomy with Biodentine™ in symptomatic young permanent teeth with carious exposure.J Endod. 2018; 44: 932-937
- Partial pulpotomy in mature permanent teeth with clinical signs indicative of irreversible pulpitis: a randomized clinical trial.J Endod. 2017; 43: 1417-1421
- Assessment of mineral trioxide aggregate pulpotomy in mature permanent teeth with carious exposures.Int Endod J. 2017; 50: 117-125
- Long-term pulpal and restorative outcomes of pulpotomy in mature permanent teeth.J Endod. 2020; 46: 383-390
- Partial pulpotomy with two bioactive cements in permanent teeth of 6- to 18-year-old patients with signs and symptoms indicative of irreversible pulpitis: a noninferiority randomized controlled trial.Int Endod J. 2019; 52: 749-759
- Clinical and radiographic evaluation of adhesive pulp capping in primary molars following hemostasis with 1.25% sodium hypochlorite: 2-year results.Am J Dent. 2007; 20: 182-188
- Pulpal response to prolonged dentinal exposure to sodium hypochlorite.Int Endod J. 2000; 33: 505-508
- Vital pulp therapy with new materials: new directions and treatment perspectives—permanent teeth.J Endod. 2008; 34: S25-S28
- Direct pulp capping with mineral trioxide aggregate: an observational study.J Am Dent Assoc. 2008; 139: 305-315
- Will mineral trioxide aggregate replace calcium hydroxide in treating pulpal and periodontal healing complications subsequent to dental trauma? a review.Dental Traumatol. 2012; 28: 25-32
- Mineral trioxide aggregate and other bioactive endodontic cements: an updated overview– part I: vital pulp therapy.Int Endod J. 2018; 51: 177-205
- Long- term outcomes of pulpotomy in permanent teeth with irreversible pulpitis: A multi- center randomized controlled trial.Am J Dent. 2017; 30: 151-155
- Pulpotomy of carious vital teeth with periapical involvement.Int Endod J. 1995; 28: 172-176
- Success of pulpotomy in the management of hyperplastic pulpitis.Int Endod J. 1993; 26: 142-148
- Evidence for bacterial causation of adverse pulpal responses in resin-based dental restorations.Crit Rev Oral Biol Med. 2000; 11: 467-480
- Response of human pulps following acid conditioning and application of a bonding agent in deep cavities.Dental Mater. 2002; 18: 543-551
- The properties of a new endodontic material.J Endod. 2008; 34: 990-993
- Dental injury models: experimental tools for understanding neuroinflammatory interactions and polymodal nociceptor functions.Crit Rev Oral Biol Med. 1999; 10: 4-39
- Evaluation of human osteosarcoma cell line genotoxicity effects of mineral trixoide aggregate and calcium silicate cements.J Endod. 2010; 36: 1158-1162
- Response of the pulp of dogs to capping with mineral trioxide aggregate or a calcium hydroxide cement.Dent Traumatol. 2001; 17: 163-166
- Spectrophotometric analysis of coronal tooth discoloration induced by various bioceramic cements and other endodontic materials.J Endod. 2015; 41: 1862-1866
- Effect of Biodentine™ on the proliferation, migration and adhesion of human dental pulp stem cells.J Dent. 2014; 42: 490-497
- Bioactivity potential of EndoSequence BC RRM putty.J Endod. 2016; 42: 615-621
- New nanostructural biomaterials based on active silicate systems and hydroxyapatite: characterization and genotoxicity in human peripheral blood lymphocytes.Int Endod J. 2013; 46: 506-516
- Direct contact with mineral trioxide aggregate activates and differentiates human dental pulp cells.J Endod. 2011; 37: 1691-1695
- Mineral trioxide aggregate–a review.J Clin Pediatr Dent. 2009; 34: 1-7
- Effect of bioceramic materials on proliferation and odontoblast differentiation of human stem cells from the apical papilla.J Endod. 2018; 44: 1270-1275
- Antifungal activity of endosequence root repair material and mineral trioxide aggregate.J Endod. 2014; 40: 1815-1819
- Inflammatory cytokines reaction elicited by root-end filling materials.J Biomed Mater Res B Appl Biomater. 2005; 73: 123-128
- Bacterial entombment by intratubular mineralization following orthograde mineral trioxide aggregate obturation: a scanning electron microscopy study.Int J Oral Sci. 2014; 6: 227-232
- Understanding mineral trioxide aggregate/Portland-cement: a review of literature and background factors.Eur Arch Paediatr Dent. 2009; 10: 93-97
- Hydration characteristics of zirconium oxide replaced Portland cement for use as a root-end filling material.Dental Materials. 2011; 27: 845-854
- Properties of NeoMTA Plus and MTA Plus cements for endodontics.Int Endod J. 2017; 50: e83-e94
- Mineral trioxide aggregate and other bioactive endodontic cements: an updated overview– part II: other clinical applications and complications.Int Endod J. 2018; 51: 284-317
- Clinical and radiographic evaluation of Biodentine™ and mineral trioxide aggregate in revascularization of non-vital immature permanent anterior teeth (randomized clinical study).Int J Paediatr Dent. 2019; 29: 464-473
- A prospective clinical study of mineral trioxide aggregate for partial pulpotomy in cariously exposed permanent teeth.J Endod. 2006; 32: 731-735
- Direct pulp capping with calcium hydroxide, mineral trioxide aggregate, and Biodentine™ in permanent young teeth with caries: a randomized clinical trial.J Endod. 2017; 43: 1776-1780
- Randomized control trial comparing calcium hydroxide and mineral trioxide aggregate for partial pulpotomies in cariously exposed pulps of permanent molars.Int Endod J. 2014; 47: 835-842
- Clinical evaluation of direct pulp capping using a calcium silicate cement-treatment outcomes over an average period of 2.3 years.Clin Oral Investig. 2019; 23: 3491-3499
- Comparison of CaOH with MTA for direct pulp capping: a PBRN randomized clinical trial.J Dent Res. 2013; 92: 16S-22S
- Mineral trioxide aggregate or calcium hydroxide direct pulp capping: an analysis of the clinical treatment outcome.J Endod. 2010; 36: 806-813
- Calcium hydroxide vs mineral trioxide aggregates for partial pulpotomy of permanent molars with deep caries.Eur Arch Paediatr Dent. 2007; 8: 99-104
- Outcome of direct pulp capping with mineral trioxide aggregate: a prospective study.J Endod. 2015; 41: 1026-1031
- Treatment outcome of mineral trioxide aggregate or calcium hydroxide direct pulp capping: long-term results.J Endod. 2014; 40: 1746-1751
- Influence of the restoration quality on the success of pulpotomy treatment: a preliminary retrospective study.J Appl Oral Sci. 2005; 13: 72-77
- MTA pulpotomy as an alternative to root canal treatment in children's permanent teeth in a dental public health setting.J Dent. 2014; 42: 1390-1395
- Treatment outcomes of pulpotomy in permanent molars with irreversible pulpitis using biomaterials: a multi-center randomized controlled trial.Acta Odontol Scand. 2013; 71: 130-136
- Five-year results of vital pulp therapy in permanent molars with irreversible pulpitis: a non-inferiority multicenter randomized clinical trial.Clin Oral Investig. 2014;
- One-year results of vital pulp therapy in permanent molars with irreversible pulpitis: an ongoing multicenter, randomized, non-inferiority clinical trial.Clin Oral Investig. 2013; 17: 431-439
- Two-year results of vital pulp therapy in permanent molars with irreversible pulpitis: an ongoing multicenter randomized clinical trial.Clin Oral Investig. 2014; 18: 635-641
- Prognostic factors in direct pulp capping with mineral trioxide aggregate or calcium hydroxide: 2- to 6-year follow-up.Clin Oral Investig. 2017; 21: 357-367
- Comparison of mineral trioxide aggregate and calcium hydroxide as pulpotomy agents in young permanent teeth (apexogenesis).Pediatr Dent. 2006; 28: 399-404
- Comparative evaluation of postoperative pain and success rate after pulpotomy and root canal treatment in cariously exposed mature permanent molars: a randomized controlled trial.J Endod. 2017; 43: 1953-1962
- Pulpotomy in caries-exposed immature permanent molars using calcium-enriched mixture cement or mineral trioxide aggregate: a randomized clinical trial.Int J Paediatr Dent. 2013; 23: 56-63
- Correlation between clinical and histologic pulp diagnoses.J Endod. 2014; 40: 1932-1939
- Is pulpotomy a valid treatment option for irreversible pulpitis?.Dtsch Zahnärztl Z Int. 2021; 3: 80-87
Article info
Publication history
Footnotes
About This Document: The following statement was prepared by the AAE Special Committee on Vital Pulp Therapy.
Distribution Information: AAE members may reprint this position statement for distribution to patients or referring dentists.
The guidance in this statement is not intended to substitute for a clinician's independent judgment in light of the conditions and needs of a specific patient.